Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy in a combination regimen used ...
Retire your old mop and bucket. The best robot mops we've tested keep your floors squeaky clean with little effort on your part. I’m PCMag’s senior writer covering smart home and wearable devices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback